RF
47
3
EW
53
-2
GME
54
-3
FLS
69
-2
JWN
61
5
AN
50
-5
JNJ
36
3
CMG
69
-4
AVGO
88
27
XEL
53
-2
LEN
45
3
NFLX
74
-2
T
48
3
WBA
64
4
GOOG
81
-2
RSG
62
-2
NEM
46
-2
CCI
23
-2
DVA
63
-2
PBI
59
-7
RF
47
3
EW
53
-2
GME
54
-3
FLS
69
-2
JWN
61
5
AN
50
-5
JNJ
36
3
CMG
69
-4
AVGO
88
27
XEL
53
-2
LEN
45
3
NFLX
74
-2
T
48
3
WBA
64
4
GOOG
81
-2
RSG
62
-2
NEM
46
-2
CCI
23
-2
DVA
63
-2
PBI
59
-7
Financhill
Back

Cytek Biosciences Stock Predictions

The dark truth about AI

Click here to learn more...
Buy
63

CTKB
Cytek Biosciences

Last Price:
6.21
Seasonality Move:
-19.47%

7 Day Trial

ALL ACCESS PASS

$ 7

Zero Day Options Trade LIVE Tuesday at 2 p.m. ET!

Discover The Zero Day Loophole (BEFORE Tues at 2 p.m. ET!)

Cytek Biosciences Stock Forecast

  • Over the next 52 weeks, Cytek Biosciences has on average historically fallen by 27.7% based on the past 3 years of stock performance.
  • Cytek Biosciences has fallen lower in 3 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 100%
  • Is Cytek Biosciences Stock Undervalued?
    The current Cytek Biosciences [CTKB] share price is $6.21. The Score for CTKB is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
  • CTKB is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.

Will Cytek Biosciences Stock Go Up Next Year?

  • Over the next 52 weeks, Cytek Biosciences has on average historically fallen by 27.7% based on the past 3 years of stock performance.

Cytek Biosciences Stock Rating

Buy
63
Cytek Biosciences (CTKB) is a Buy

Is Cytek Biosciences overpriced?

  • Cytek Biosciences has fallen lower in 3 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 100%

Cytek Biosciences Stock Price History

Is CTKB stock going to rise?

  • The current trend is moderately bearish and CTKB is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Life Sciences Tools & Services
Sector:
Health Care
Type:
stock
Website:
cytekbio.com

52-Week Data

52-Week High:
9.87
52-Week Low:
4.66

Prediction Charts

Market Cap:
799.91M
Price in USD:
6.21
Volume:
537.17K
Beta:
1.49

Technical Analysis

SMA50:
5.90
SMA100:
5.70
SMA200:
5.96
52-Wk Change:
-22.57%

Stock Predictions

  • Is Cytek Biosciences stock public?
    Yes, Cytek Biosciences is a publicly traded company.
  • What is the Cytek Biosciences stock quote today?
    The Cytek Biosciences stock price is 6.21 USD today.
  • How to buy Cytek Biosciences stock online?
    You can buy Cytek Biosciences shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-25 6.68 6.69 6.83 6.51
Nov-26 6.60 6.41 6.63 6.29
Nov-27 6.49 6.50 6.56 6.40
Nov-29 6.54 6.53 6.61 6.46
Dec-2 6.50 6.92 6.93 6.37
Dec-3 6.88 6.71 6.90 6.62
Dec-4 6.68 6.69 6.81 6.52
Dec-5 6.65 6.54 6.77 6.52
Dec-6 6.61 6.47 6.85 6.42
Dec-9 6.49 6.80 6.88 6.47
Dec-10 6.83 6.73 6.89 6.63
Dec-11 6.83 6.56 6.89 6.46
Dec-12 6.51 6.47 6.60 6.41
Dec-13 6.43 6.21 6.43 6.11

Cytek Biosciences Earnings

Cytek Biosciences Earnings Report: Per Share Cytek Biosciences Earnings Q1 Q2 Q3 and Q4 last year and next year.

Cytek Biosciences Forecast Revenue Growth

Cytek Biosciences Stock Analysis: Historical quarterly revenues per share for Cytek Biosciences and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.06 per share, and an increase next year of $0.11 per share.

* Cytek Biosciences stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.